Professional
Added to YB: 2026-01-23
Pitch date: 2024-06-13
ESTA [bullish]
Establishment Labs Holdings Inc.
+60.39%
current return
Author Info
No bio for this author
Company Info
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States.
Market Cap
$2.0B
Pitch Price
$44.41
Price Target
200.00 (+181%)
Dividend
N/A
EV/EBITDA
-129.09
P/E
-46.97
EV/Sales
9.64
Sector
Health Care Equipment and Supplies
Category
growth
Establishment Labs (ESTA) Investment Memorandum
ESTA: Costa Rica-based breast implant maker with superior Motiva implant (1% complication rate vs 15.9% Allergan). FDA approval expected Q3 2024 for US launch. Market share grew 7%→15% non-US, targeting 30% by 2029. Mia minimally-invasive procedure rolling out 100 centers in 2024. $200 price target.
Read full article (21 min)